Loading...
Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
BACKGROUND: Egypt has the highest prevalence of a difficult to treat chronic hepatitis C virus (HCV), genotype 4. Pretreatment factors could guide individualization of therapy which aids in treatment optimization and interleukin IL28B gene polymorphism has been shown to closely relate to HCV treatme...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839712/ https://ncbi.nlm.nih.gov/pubmed/27100663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0153895 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|